A randomized trial of chlorhexidine gluconate on oral bacterial pathogens in mechanically ventilated patients

Abstract

Introduction: Dental plaque biofilms are colonized by respiratory pathogens in mechanically-ventilated intensive care unit patients. Thus, improvements in oral hygiene in these patients may prevent ventilator-associated pneumonia. The goal of this study was to determine the minimum frequency (once or twice a day) for 0.12% chlorhexidine gluconate application necessary to reduce oral colonization by pathogens in 175 intubated patients in a trauma intensive care unit.

Methods: A randomized, double-blind, placebo-controlled clinical trial tested oral topical 0.12% chlorhexidine gluconate or placebo (vehicle alone), applied once or twice a day by staff nurses. Quantitation of colonization of the oral cavity by respiratory pathogens (teeth/denture/buccal mucosa) was measured.

Results: Subjects were recruited from 1 March, 2004 until 30 November, 2007. While 175 subjects were randomized, microbiologic baseline data was available for 146 subjects, with 115 subjects having full outcome assessment after at least 48 hours. Chlorhexidine reduced the number of Staphylococcus aureus, but not the total number of enterics, Pseudomonas or Acinetobacter in the dental plaque of test subjects. A non-significant reduction in pneumonia rate was noted in groups treated with chlorhexidine compared with the placebo group (OR = 0.54, 95% CI: 0.23 to 1.25, P = 0.15). No evidence for resistance to chlorhexidine was noted, and no adverse events were observed. No differences were noted in microbiologic or clinical outcomes between treatment arms.

Conclusions: While decontamination of the oral cavity with chlorhexidine did not reduce the total number of potential respiratory pathogens, it did reduce the number of S. aureus in dental plaque of trauma intensive care patients.

Trial registration: ClinicalTrials.gov NCT00123123.

Figures

Figure 1

Study design. The final analysis was based on subjects having a microbiologic assessment at baseline and for at least the 48 hour (h) time point (n = 42 in the placebo group, 36 in the chlorhexidine gluconate (CHX) once a day group, and 37 in the CHX twice a day group).

Figure 2

Effect of topical CHX on dental plaque scores (mean) and 95% confidence intervals. Triangle = placebo; Square = chlorhexidine gluconate (CHX) once a day; Circle = CHX twice a day. Days represent duration following mechanical ventilation. The confidence intervals were obtained based on data at each time point.

Figure 3

Effect of topical chlorhexidine gluconate on the number of potential respiratory bacterial pathogens in oral samples. Mean in log scale with 95% confidence intervals. The confidence intervals were obtained based on data at each time point. Triangle = placebo; Square = chlorhexidine gluconate (CHX) once a day; Circle = CHX twice a day.

Figure 4

Effect of topical chlorhexidine gluconate on the number of Staphylococcus aureus in oral samples. Mean in log scale with 95% confidence intervals. The confidence intervals were obtained based on data at each time point. Triangle = placebo; Square = chlorhexidine gluconate (CHX) once a day; Circle = CHX twice a day.

Figure 5

Effect of CHX on mean clinical pulmonary infection score with 95% confidence intervals. Triangle = placebo; Square = chlorhexidine gluconate (CHX) once a day; Circle = CHX twice a day. The confidence intervals were obtained based on data at each time point.